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Abstract
Peptide inhibitors of Methuselah (Mth), a G protein-coupled receptor (GPCR), were reported that
can extend the lifespan of Drosophila melanogaster. Mth is a class B GPCR, which is characterized
by a large, N-terminal ectodomain that is often involved with ligand recognition. The crystal structure
of the Mth ectodomain, which binds to the peptide inhibitors with high affinity, was previously
determined. Here we report the predicted structures for RWR motif peptides in complex with the
Mth ectodomain. We studied representatives of both Pro-class and Arg-class RWR motif peptides
and identified ectodomain residues Asp139, Phe130, Asp127, and Asp78 as critical in ligand binding.
To validate these structures we predicted the effects of various ligand mutations on the structure and
binding to Mth. The binding of five mutant peptides to Mth was characterized experimentally by
surface plasmon resonance, revealing measured affinities that are consistent with predictions. The
electron density map calculated from our MD structure compares well with the experimental map of
a previously determined peptide/Mth crystal structure and could be useful in refining the current low-
resolution data. The elucidation of the ligand binding site may be useful in analyzing likely binding
sites in other class B GPCRs.
G protein-coupled receptors (GPCRs1) constitute a superfamily of transmembrane proteins
that play critical roles in transmitting extracellular signals to the interior of the cell. Methuselah
(Mth) is a class B (secretin-like) GPCR that was previously shown to be involved in stress
response and biological aging (1). Like other class B GPCRs, Mth has a large (195 residues)
amino-terminal extracellular domain essential for ligand-binding (2). However, the sequence
similarity of the mth gene to other class B GPCRs is observed solely within the transmembrane
regions (1). The crystal structure shows that the Mth ectodomain consists primarily of β-sheets
(3), revealing a topology distinct from that of other hormone receptors such as the corticotropin-
releasing factor (CRF) or glucose-dependent insulinotropic polypeptide (GIP) receptors (4,5).
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Recently Ja et al. reported a series of peptide antagonists that inhibit Mth signaling and extend
Drosophila melanogaster lifespan (6). Since the extracellular N-terminal domains of other
hormone GPCRs have been shown to be properly folded and function in ligand-binding (7–
9), Ja et al. used mRNA display selection to identify high-affinity peptide ligands targeting the
Mth ectodomain (6). The selected peptides contain a highly conserved consensus— [R/P]
xxWxxR—which is denoted as the RWR motif. The crystal structure of a selected peptide and
the ectodomain complex was reported, but the coordinates of the ligand could not be resolved.
Therefore it was not possible to extract the detailed atomistic description of the ligand-receptor
interactions that would be critical in understanding the properties of the binding site.
Here we use computational tools to predict atomistic models of the Mth ectodomain complex
structure for four high-affinity peptide ligands. We also compute the electron density map with
our atomistic structure of the complex for comparison with the experimental map (6). We then
use our predicted structure to carry out a computational mutagenesis study that suggests
alternative peptide ligands that might improve or diminish the binding affinity. Experimental
measurements of binding affinity for five mutant peptides are subsequently performed and
found to be consistent with our predictions. Our predicted structures suggest additional
experimental validation studies that could be helpful in characterizing the binding of other Mth
ligands.
METHODS
Modeling of the Mth ectodomain
Two X-ray crystal structures of the Mth ectodomain (the N-terminal 188 residues of Mth
without the signal sequence) were published with and without a peptide inhibitor in complex
(PDB ID: 2PZX and 1FJR, respectively) (3,6). The resolution for the co-crystal structure was
not sufficient to determine the coordinates for the ligand. Since the RMSD of Cα atoms between
these two X-ray structures is 0.65 Å, we chose the structure with the better resolution (PDB
ID: 1FJR). We then refined this crystal structure computationally by equilibrating it in explicit
water solvent for 1 ns. Only chain A was extracted from the dimer in the unit cell. Two Pb2+
ions close to Asp or Glu residues were replaced with Zn2+ ions and the water molecules within
5 Å from the protein were retained. The hydrogen atoms were placed using the Whatif program
(10). The system was fully solvated into an equilibrated water box of 64×74×70 Å3 using the
Visual Molecular Dynamics (VMD) molecular graphics program (11). The VMD autoionize
plugin was then used to randomly place the ions necessary to neutralize the system. The
resulting system contained 27,643 atoms within the periodic unit cell; 2,993 protein atoms,
24,642 water atoms, 2 Zn2+ and 6 Na+ atoms.
The system was minimized using 5000 conjugate gradient steps and equilibrated subsequently
at 310 K for 100 ps while the protein coordinates were kept fixed. Next, the full system was
minimized using 5000 conjugate gradient steps with no restraints and then equilibrated at 100
K for 1 ns. This equilibrated system was finally subjected to 5000 steps of conjugate gradient
minimization. This system was gradually heated from 0 K to the target temperature using
Langevin molecular dynamics with a damping coefficient of 1 ps−1. A constant pressure of 1
atm was maintained using the Langevin piston method.
All simulations used periodic boundary conditions and the electrostatic interactions were
computed using the Particle Mesh Ewald (PME) method. The simulations were carried out
with the NAMD 2.6 (12) parallel molecular dynamics code using the CHARMM22 forcefield
(FF) (13,14) for proteins and the TIP3P water model (15).
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Building the peptide ligands
Two peptides representing the Pro- and Arg-classes of RWR motif peptides (LP1 and LR1 in
Table 1) were built as canonical α-helices using the Biograf program. Based on the spacing of
the critical residues in the RWR motif, the ligand regions contacting the binding site are likely
to be helical. The side chains of the peptide were replaced using the SCREAM side chain
optimization program (V. W. T. Kam and W. A. Goddard III, to be published ). These side
chain conformations were further optimized with three cycles of annealing molecular dynamics
using the SGB implicit solvent protocol (16). The isolated helix was heated from 50 K to 600
K and cooled down to 50 K in 50 K temperature steps while the coordinates of the backbone
atoms were fixed. At each temperature the equilibration was carried out for 300 fs. The
annealing MD was performed using the DREIDING FF (17) with the charges from
CHARMM22. MPSim was used for all energy and force calculations (18). The cell multipole
method was used for the calculation of non-bonded interactions (19).
The optimized helix structure was then equilibrated in explicit water solvent as described
previously. The equilibration was performed at 100 K for 1 ns, then 200 K for 1 ns and 310 K
for 1 ns. The equilibrated structure was minimized with a conjugate gradient of 5000 steps and
used for the docking study.
Docking of the LP1 ligand to the Mth ectodomain
To search for the LP1 peptide binding site on the Mth ectodomain, rigid docking was carried
out using ZDOCK (20). The search area on Mth was limited to residues 126–144, 148–159,
and 164 –188, based on the approximate binding regions provided by the electron density map
from the experimental crystal structure of the LP1–Mth ectodomain complex (6). From the
2000 configurations generated, we selected the 80 configurations in which the N…O distance
of the salt-bridge between R8 and Asp139 was within 4 Å.2 Here we assumed a close interaction
between R8 in LP1 (which is one of the critical residues identified in the previous study) and
Asp139. Asp139 is a negatively charged residue present in the putative binding crevice. The
side chain conformations of the peptide ligands were replaced using SCREAM and then the
ligands were minimized with 50 conjugate gradient steps. These calculations, including the
following optimization steps, were carried out using the DREIDING FF and CHARMM22
charges with the MPSim MD code (18).
Among the top 20 configurations ranked by the interaction energy (sum of intermolecular
Coulombic, van der Waals and hydrogen bond energies), we chose two configurations in which
W5, another residue critical for receptor binding, had favorable interactions with Mth. These
two ligand-protein complexes were further optimized as follows: the ligand was subjected to
conjugate gradient minimization to an RMS force of 0.5 kcal/mol/Å followed by 10 ps NVT
dynamics at 50 K using SGB implicit solvent; then we minimized it to an RMS force of 0.3
kcal/mol/Å. We next used SCREAM to replace side chain conformations of the peptide ligand
and of Mth residues within 3 Å from the ligand. Finally, the entire complex structure was
minimized to 0.3 kcal/mol/Å of RMS force with conjugate gradient. The structures for both
complexes were subsequently equilibrated in an explicit water box as described previously.
The water box was chosen to extend by ~8 Å from all atoms of the complex. This equilibration
was carried out for 3 ns (100K for 1 ns, then 200K for 1 ns and 310 K for 1 ns).
Docking of the LR1 ligand to the Mth ectodomain
The LR1 peptide was docked to the receptor by matching the Cα atoms of residues 5–8 (which
include the key W5 and R8 residues of the RWR motif) to those of the LP1 ligand in the
2Throughout the text, the Mth ectodomain residues are denoted by their three-letter abbreviations while peptide ligand residues are
denoted by their one-letter codes.
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equilibrated structure of the complex. From the last 500 ps of the 1 ns MD trajectory for the
LR1 ligand we selected 4 snapshots out of 50 (the snapshots were taken every 10 ps) that had
no clashes with the receptor after being matched and minimized them further. Side chains of
the ligand and of receptor residues within 3.5 Å of the ligand were replaced using SCREAM
and the complex structure was minimized to an RMS force of 0.5 kcal/mol/Å. The final best
complex structure was chosen based on the FF energy and subsequently equilibrated in the
explicit water solvent by following the same procedures as for the LP1 ligand complex. Here
we extended the equilibration time to 3 ns at 310 K to allow for full conformational relaxation
of the docked ligand since the LR1 ligand has an internal proline residue that induced a kink
in the helix of the equilibrated free ligand. To decrease the equilibration time scale and assist
conformational change, the side chain conformations in the cavity around R2 of the ligand
(which was expected to be critical in interacting with the receptor (6)) were re-assigned using
SCREAM. After replacement, the complex was further equilibrated for 1 ns. This newly
assigned complex structure showed better interaction energy (−407.77±25.88kcal/mol) than
the original complex structure (−389.61±38.18kcal/mol). Here the interaction energy includes
electrostatic and van der Waals interactions and is averaged over the last 1 ns trajectory.
Computational mutagenesis study
Starting from the 1 ns-equilibrated Mth/LP1 complex structure, five residues (W5, R8, Y9,
L11 and R15) of the LP1 ligand were selected for computational mutagenesis. For each of
these 5 residues we considered the 19 natural amino acids excluding proline. We selected 10
sidechain conformations using SCREAM with the 0.1 Å rotamer library, then we conjugate
gradient minimized for 10 steps with MPSim and selected the rotamer with the best energy.
To reduce the bias in interaction energies due to electrostatic interactions with charged groups,
each charged residue was neutralized by protonating or de-protonating before calculating the
differential interaction energy. The structure of the ligand protein complex was minimized to
0.25 kcal/mol/Å of the RMS force after the neutralization step. The energies from these
calculations are listed in Table 2.
Based on these calculations we selected five mutations of the LP1 ligand (W5K, W5F, Y9F,
L11Q and R15Q) as good tests of our predicted ligand-protein structure (the reason why they
were chosen is explained in the Results and Discussion section). Each of these was equilibrated
in explicit water solvent to allow for conformational relaxation due to perturbation from
mutation. To minimize the effect of the initial solvent and ion configurations on conformational
change, we started with the fully solvated wild-type (WT) complex structure and mutated the
corresponding residue with the same mutant rotamer previously optimized. Any water
molecules that clashed were removed. The system was re-neutralized by adding or deleting
Cl− counter-ions as necessary. Each system was first subjected to a minimization of 1000 steps
and then the solvent molecules were equilibrated for 100 ps at 310 K while the coordinates of
Mth/ligand complex structure were fixed. Finally, the entire system was equilibrated for 2 ns
at 310 K. The MD simulation was carried out with the NAMD 2.6 program as described
previously.
Experimental binding analysis of peptides using surface plasmon resonance (SPR)
LP1 (FPSSWLQRYYLAKRR) and mutant peptides (W5K, W5F, Y9F, L11Q and R15Q) were
synthesized and purified (>95%) by Genscript Corp. (Piscataway, NJ) with N-terminal
acetylation and C-terminal amidation. Lyophilized peptides were dissolved in ddH2O and
quantitated by measuring absorbance at 280 nm. C-terminal biotinylated Mth ectodomain was
prepared as described previously (6). SPR measurements were performed at 25 °C on a Biacore
T100 instrument (Biacore, Piscataway, NJ). A CM5-streptavidin chip was prepared in-house
by standard NHS/EDC amine coupling (Biacore) and achieved ~6000 RU of immobilized
streptavidin per flow cell. Biotinylated Mth ectodomain was immobilized to different flow
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cells of the CM5-streptavidin chip to surface densities of approximately 500, 600, and 800 RU.
HBS-EP+ (Biacore, 10 mM HEPES at pH 7.4, 150 mM NaCl, 3 mM EDTA, and 0.05% v/v
Surfactant P20) was used as the running buffer and Flow cell 1 was left as a streptavidin
negative control for all experiments. To collect kinetics data, a concentration series for each
peptide was injected for 90 s at a flow rate of 100 μL/min. Numerous buffer blank injections
were also included for double referencing with the streptavidin negative control surface.
Peptides were allowed to dissociate for >5 min, which allowed the signal to return to baseline
before injection of the next sample. Raw data were processed with Biacore T100 Evaluation
Software using a 1:1 bimolecular interaction model and KD values were calculated (kd/ka) from
the determined on and off rates. Rate constants were determined from each Mth-containing
flow cell and are reported as averages (± s.d.) except for the W5F mutant, which yielded
measurable data from only the flow cell with the highest density of immobilized Mth
ectodomain.
RESULTS AND DISCUSSION
In silico equilibration of apo receptor and free peptide ligands
After the Mth ectodomain was equilibrated in the explicit water box for 1 ns, we found that
the overall folding topology remained the same as the initial X-ray crystal structure (RMSD
of Cα atoms = 0.47 Å). This indicates that the force field parameters describe our current system
well. The LP1 ligand remained in the initial α-helical conformation during the 1 ns equilibration
and for the LR1 ligand we observed the proline kink in the middle of the helix, as expected.
The bend angle was 27.5° for the final equilibrated structure after 1 ns and 17.5° for the
conformation showing the best FF energy after docking (snapshot at 940 ps).
Characterization of the predicted binding site of the LP1 peptide ligand
After equilibration of two candidate ligand-protein complexes at 310 K for 1 ns, the interactions
between the LP1 ligand and the receptor were identified. We then selected the putative ligand-
protein structure (1 ns snapshot of Fig. 1) based on the nature of the important non-bonding
intermolecular interactions and the interaction energy (−347.68±27.23 kcal/mol vs. −213.31
±24.44 kcal/mol, averaged over 1 ns). This final complex structure was further equilibrated
for 5 ns. Three representative snapshots at 1 ns, 3 ns and 5 ns are shown in Fig. 1, along with
the initial minimized structure. Fig. 2 presents the changes in distances over the 5 ns
equilibration for several key residue pairs involved in the intermolecular interactions.
Two defining residues of the RWR motif, W5 and R8, were previously determined to be critical
in binding to Mth (6). The initial predicted structure has W5 making favorable hydrophobic
interactions with the aromatic residues Phe130 (5.0 Å at 1 ns, the centroid-to-centroid distance)
and Phe153 (6.1 Å). However, the contact with Phe153 loosens after 1.5 ns (~8.0 Å). The
indole nitrogen of W5 also forms a hydrogen bond with Asp139, which is quite stable during
the 5 ns (remaining at ~3 Å).
The other key residue, R8, interacts via salt-bridge with Asp139 (~2.6 Å), which remains buried
and constant during the dynamics (Fig. 2-(b)). R8 also forms a salt-bridge with Glu136 at early
times (2.77 Å at 1 ns), but this becomes weaker later (4.46 Å at 5 ns). R8 also forms a hydrogen
bond (~2.7 Å) with the backbone carbonyl oxygen of Tyr131.
At the C-terminus of the ligand, R15 makes a salt-bridge with Asp127 (2.67 Å at 1 ns). Since
R15 is exposed to solvent, we find fluctuations in the distance between R15 and Asp127, from
2.7 and 15 Å, as water molecules move in and out. Interestingly, R15 switches its interaction
to Asp78 after 2 ns and then back to Asp127 after 4 ns (Fig. 2-(a)). R15 is located at the terminus
of the ligand, which allows for this conformational flexibility. These two Asp residues present
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in different loop regions enable R15 to maintain receptor interactions while remaining free to
sweep through space. Hence, this binding interaction is likely to have some favorable aspects
of both enthalpy and entropy. Arginine residues C-terminal to the RWR motif are weakly
conserved in the previously identified peptide ligands (6), with the location of the Arg residues
varying by several residues between sequences. The presence of these Asp residues in the loop
regions of Mth could explain this variation.
We identified two other favorable contacts: F1 initially interacts closely with Phe153 and later
the backbone nitrogen forms a salt-bridge with Glu137 (at 3 ns) and then Glu136 (at 5 ns). We
find that P2, which is one of the consensus residues of the RWR motif, does not interact directly
with the receptor. However, the flexibility in the conformation induced by Pro likely plays a
role in permitting F1 to make contacts with the receptor. In addition, S4 contacts Glu136
through hydrogen bonding, but with fluctuations.
Characterization of the predicted binding site of the LR1 peptide ligand
Binding of the LR1 ligand to the Mth ectodomain reduces the kink induced by the proline
residue (from a bend angle of 17.5° to <10°). The intermolecular contacts between the LR1
ligand and the ectodomain are shown in Fig. 3 after equilibration for 5 ns. W5 and R8 show
the same interactions with the ectodomain as for the LP1 ligand, except that Glu136 no longer
interacts with the peptide. S4 of LP1, which interacts with Mth Glu136, is replaced with V4
in the LR1 ligand. This leaves Glu136 in the LR1/Mth complex exposed and solvated with
water molecules. Therefore, we would expect that mutation of Glu136 might reduce the binding
affinity for the LP1 ligand preferentially and assaying this mutation could provide validation
for our prediction.
R2, a critical residue of the conserved RWR motif, shows favorable electrostatic interaction
with Asp154. This contact is fairly stable throughout the equilibration as shown in Fig. 4-(c).
R2 also contacts the side chain of Gln138 through a hydrogen bond, which is formed after 1
ns and preserved thereafter.
R15 forms a salt-bridge with Asp78 as observed in the LP1 case. However in the LR1 case this
interaction remains tight throughout the equilibration since the C-terminus of the LR1 ligand
is extended from R15 by additional residues. R17 is in the proximity of Asp127, but appears
to interact weakly. During the first 1 ns equilibration, the N…O distance between them
fluctuates between 2.5 and 10.5 Å. After ~1.7 ns R17 gets closer to Asp127, but a water
molecule still intervenes between them occasionally.
F12 has a strong aromatic interaction with Tyr131 and its backbone carbonyl group forms a
hydrogen bond with Asn79 at earlier times. The carbonyl group of M1 also contacts Gln138.
The interaction energy between the ligand and the ectodomain was averaged over the last 4 ns
to compare the energetics between the LP1 and LR1 ligand cases. The LR1 ligand showed
better interaction energy than the LP1 ligand (−437.34±44.58 kcal/mol vs. −310.97±78.33 kcal/
mol), in qualitative agreement with experimental binding affinities (6). The relatively large
standard deviation for the LP1 case reflects greater conformational fluctuations, indicating that
the binding of the LP1 ligand would be entropically more favorable as previously described.
Characterization of the predicted binding sites of the LP2 and LR2 ligands
The LP2 ligand has seven additional amino acids extended from the N-terminus of LP1 (Table
1). Starting with the 1 ns-equilibrated Mth/LP1 complex structure in Fig. 1, we added these
seven residues in the α-helical conformation. The torsion angles for the unraveled amino-
terminal F-P in the LP1 ligand were modified to be α-helical. However this full α-helix
conformation caused a clash with the receptor and therefore these additional seven residues
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likely form a random coil. In any case, they would not have much contact with the receptor
since they are hung peripherally. This may explain the similar binding affinities between the
LP1 and LP2 peptides, measured previously (6).
The structure of the Mth/LR2 complex was built from the Mth/LR1 structure by using
SCREAM to mutate the corresponding residues. Since the LR2 ligand does not have the proline
that caused the kink in LR1 (it was replaced with phenylalanine), the torsion angle was modified
to assume a straight α-helix conformation after replacement of the amino acids. The two
additional amino-terminal residues in LR2 were built in the extended conformation first and
then optimized with annealing molecular dynamics. The final equilibrated complex structure
is shown in Fig. S1. During the entire trajectory of the 1 ns equilibration, three arginine residues
common with the LR1 ligand formed salt-bridges with Asp residues of the receptor. The
aromatic interactions of W7 from the LR2 ligand (corresponding to W5 of the LR1 peptide)
also remain stable.
Comparison of predicted and experimental electron density maps
We computed the electron density map from our Mth/LP1 complex structure using the CCP4
program suite (21) for comparison with the experimental density map published in the previous
study (6). The unit cell for the Mth/LP1 complex structure was built with the same space group
as the crystal structure (PDB ID: 2PZX). Starting with the structure factor file deposited in the
Protein Data Bank, we recalculated the structure factors and phases for our complex structure
and computed the electron density map. The density map covering the peptide ligand for the
5 ns-equilibrated structure is shown in Fig. 5-(a). The density maps also overlapped well with
the experimental density map of the ligand (Fig. 5-(b)), supporting our prediction of the LP1
peptide binding mode. These computational results could be useful in refining the relatively
low-resolution crystal structure.
Computational mutagenesis study
We carried out a computational mutagenesis study for the LP1 ligand to design better
alternative peptide ligands and also to provide candidates for mutagenesis experiments. Five
residues were considered for mutation: L11, Y9, W5, R8 and R15.
We selected L11 because it is located on the boundary of the ligand-receptor contact and is
therefore exposed to solvent even though it is nonpolar. Moreover, the nearby Asn79 has no
interaction partner. When replacing this L11 with 18 other amino acids (see Table 2 for the
energies), we found three mutations with dramatically enhanced binding energy, K (by 8.2
kcal/mol), R (by 11.4) and Q (by 5.6), with all of them forming a hydrogen bond with Asn79.
We selected L11Q for experimental measurements since the other cases would introduce
charges and hence might affect the ligand structure.
We chose Y9 as a control mutation candidate since we expected that mutations of Y9 would
have little effect on binding. Although it is close to Phe130 and W5, Y9 does not interact tightly
with the receptor. Most predicted mutations made the interaction worse (Table 2), and the
changes were small as expected. However, mutation to R enhanced the affinity due to hydrogen
bonding with the backbone carbonyl group. A conserved mutation to either F or W barely
affected binding, thus we decided to assay Y9F experimentally.
Since W5, R8 and R15 all strongly interact with the receptor, mutation of these residues
generally leads to a dramatic decrease in the calculated binding energy. One exception is the
W5K mutation, which the calculations suggested would improve binding (by ~5 kcal/mol) by
forming a salt-bridge with Asp139 (which previously made a hydrogen bond with the side
chain nitrogen of W5). In contrast, mutation of either R8 or R15 to K was predicted to not
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improve binding even though these mutations preserve the positive charge. For the R8K
mutation, the K residue can no longer reach Glu136 leading to loss of this contact. For R15K,
Asp127 formed a salt-bridge, but the binding energy was 11 kcal/mol smaller than the WT.
These results are compatible with the previous observation that Arg and not Lys is prevalent
in this region of the peptide ligands (6). To avoid inducing large conformational instability in
the peptide ligand itself, we chose to experimentally assay W5F and R15Q, in addition to W5K.
Experimental binding study of mutant ligands
Based on our computational mutagenesis predictions, we measured the binding kinetics of five
mutant ligands (L11Q, Y9F, W5F, W5K and R15Q) by SPR. The biotinylated Mth ectodomain
was immobilized on the surface of a sensor chip while the peptides were in solution. Binding
of the ligands to the Mth ectodomain was observed as a refractive index change on the sensor
chip surface and was measured in real-time in resonance units (RU).
The results with the LP1 wild-type (WT) peptide compare well with previous measurements
and may reflect slight differences in the synthetic peptides tested (peptides in this study had
N- and C-terminal acetylation and amidation, respectively) (6). The L11Q, Y9F, and R15Q
mutants exhibited similar rate constants to the WT peptide. Mutations to the strongly conserved
W5 residue drastically reduced binding, with W5F exhibiting a KD of 12 μM and W5K showing
no binding to the Mth ectodomain at the highest concentrations tested (1 μM).
Molecular dynamics simulations for mutant complex structures
In the computational mutagenesis study described above, we did not allow conformational
changes from the single-residue mutations. For optimal comparison to the experimental results,
we carried out MD simulations in explicit water solvent for the complex structures of the five
experimentally tested peptide mutants, allowing for full conformational relaxation. Indeed we
see that some initial contacts change within the 2 ns equilibration. The interactions in the core
regions composed of W5, R8, Asp139 and Phe130 remain fairly strong for all five cases, as in
the WT. We can observe some changes in contacts between the receptor and the ligand, which
vary case by case. The final equilibrated structures are shown in Fig. 6. The binding energies
for these mutant complex structures were computed in the same way as shown in Table 2 of
the computational mutagenesis study. We also calculated the non-bond interaction energy
between the ligand and the receptor residues within 5 Å from the ligand (Table 3).
i. L11Q
We made this experimental mutation because the combinatorial mutation calculations
suggested that it might increase binding by ~6 kcal/mol. However the full solvent MD
found that the initial hydrogen bond between Q11 and Asn79 is unstable, breaking
after 0.5 ns of equilibration. At 2 ns, the side chain of Q11 forms a hydrogen bond
with the hydroxyl group of Tyr131. However, this contact is water-mediated with an
average distance of ~6 Å after equilibration. Indeed the L11Q mutation caused the
salt-bridge of R15 with Asp127 to break, becoming water-mediated. However, L11Q
leads to improved hydrogen bonding of Glu136 with R8 and S4. The net result from
the MD is that L11Q improves the binding (by ~13–23 kcal/mol, as expected from
the combinatorial mutation calculations). The experiments find a slightly decreased
binding affinity (18 to 24 nM), indicating very similar binding.
ii. W5F
We expected W5F to decrease binding (by ~9 kcal/mol). Obviously, the hydrogen
bond with Asp139 shown for the indole nitrogen of W5 is no longer available for
W5F. Indeed the MD shows much decreased binding (by ~6–11 kcal/mol). The salt-
bridge interaction between R15 and Asp127 on the C-terminus of the ligand is
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preserved in the MD. However, this mutation leads to a loss of the hydrogen bonding
of F1 to the Glu residue, indicating a loosening of the N-terminus of the ligand. The
experiments find a dramatic decrease in binding (18 nM to 12 μM) as expected from
the prediction.
iii. W5K
iv. We expected from the combinatorial mutation calculations that W5K might improve
the binding (by ~5 kcal/mol). This mutation of the aromatic residue to a non-aromatic
results in the loss of hydrophobic contacts with Phe130 and Phe153. However, the
initial hydrophilic interactions remain during the 2 ns equilibration, including the
contact of K5 with Asp139. The net result from the MD is much worse binding (by
6 to 8 kcal/mol). The experiments observed no binding at the highest peptide
concentrations tested (KD >15 μM). To explore the origin of the lack of measureable
binding we carried out MD calculations for isolated W5K in water solvent (Fig. 7),
starting with the α-helical docked conformation, and found that the W5K peptide
unraveled in ~2 ns. Hence, the W5K peptide likely suffers a higher entropic cost than
that of the WT peptide upon binding to Mth. In silico, this would lead to a low
probability of observing the predicted W5K complex where the helical conformation
of the ligand was retained.R15Q
We expected from the combinatorial mutation calculations that this mutant would
have dramatically decreased binding (by ~13 kcal/mol). Indeed the MD simulation
finds that the initial hydrogen bond of Q15 with Asp127 breaks, making a salt-bridge
to R14. However, the R15Q preserves the hydrophobic interaction between W5 and
Phe153 in the MD, whereas this interaction is not preserved in the MD for the WT.
Moreover the hydrogen bond of Glu136 to S4 is lost during the MD of the R15Q
mutant. The net results from the MD is that the binding for R15Q is essentially the
same (~1 kcal/mol worse) as for the WT. The experiments find a slightly decreased
binding affinity (18 to 38 nM), indicating very similar binding.
v. Y9F
Compared with Y9 in the WT, the mutated F shows more conformational fluctuation.
The hydroxyl group of Y9 in WT holds it closer to the receptor through water-
mediated hydrogen bond with the backbone of the receptor. The centroid-to-centroid
distance between F9 and Phe130 represents this behavior (initially ~5 Å and
occasionally ~8Å (Fig. S2-(b))). W5 has the original hydrophobic contact with
Phe153, which becomes loose after further equilibration in WT. The experiments find
a slightly decreased binding affinity (18 to 49 nM) indicating very similar bonding.
To summarize, the experiments and predictions indicated that L11Q, Y9F and R15Q mutant
ligands exhibit comparable interactions to the WT LP1 peptide. We expected that W5F would
lead to worse binding, which was confirmed by the MD simulation and experimental results.
For the W5K complex, we thought that an additional hydrophilic interaction from mutation of
W5 to K might compensate for the missing aromatic interactions. However, MD simulations
of the W5K peptide alone and in complex with Mth suggested a more severe decrease in
binding, which was experimentally verified as W5K showed no measureable affinity to Mth.
The changes in binding energy are not in quantitative agreement with experiments. Several
possibilities for this include: 1) the energies in the dynamics fluctuate greatly as various charged
side groups and counter-ions move about, 2) no account is taken of the entropic effects upon
binding, and 3) the length of the dynamics might not sample all significant binding modes.
Regardless, the predictions on how the binding changes from the combinatorial mutation
calculations and the MD simulations are qualitatively consistent with experiments, indicating
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which ones should lead to comparable binding. Thus such calculations are likely to distinguish
bad binders from good binders.
CONCLUSION
The docking study of the Mth ectodomain with the peptide ligands was carried out using rigid
docking methods followed by side chain replacement and force-field based scoring. The RWR
motif of the ligands showed favorable aromatic and electrostatic interactions with the
ectodomain, demonstrating the importance of these residues on binding as suggested from the
conservation seen in the previous experimental study (6). Indeed these studies show that the
critical residues of the protein are: Asp139 interacting with W5 and R8, Phe130 with W5, either
Asp78 or Asp127 with R15 and Asp154 with R2 in the LR ligands. This provides a number of
predictions that can be subjected to experimental tests.
Using the predicted structures, we illustrate the combinatorial mutation calculation strategy to
predict interesting mutations for experimental study. This is a complement to experimental
screening or selection studies. Based on the computational mutagenesis results, we measured
the kinetics of binding of the mutant peptide ligands with the Mth ectodomain. Here we found
that conformational relaxation of the mutant complex structures from MD simulations is
essential to obtain qualitative correlations with the experiments. The computational predictions
are consistent with experiments but clearly an improvement in binding scoring will be needed
to use such methods for optimizing ligands.
It is encouraging that the current method of docking such a large peptide ligand to a receptor
protein leads to results in apparently excellent agreement with experiments. We expect that the
binding characteristics examined in this study for the Mth ectodomain will provide insight
helpful in investigating interactions between the N-terminal domains of other class B GPCRs
and their peptide ligands. To understand the overall process of GPCR function, it will be
necessary to model ligand binding to the entire receptor structure, including the transmembrane
domains. Our studies of the ectodomain-ligand binding are the first step for elucidating this
process.
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FIGURE 1.
Binding of the LP1 ligand to the Mth ectodomain after 0 ns, 1 ns, 3 ns and 5 ns equilibration.
The residues from the receptor (green) are in three-letter code and those from the ligand
(magenta) are in single-letter code. Hydrogen bonds and aromatic interactions are specified
with black dotted lines and red arrows, respectively. The HBPLUS program was used to
calculate hydrogen bonds (maximum D-A distance = 3.9 Å, minimum D-H-A angle = 90.0°).
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FIGURE 2.
Changes during 5 ns MD simulation of key intermolecular interactions in the Mth/LP1
complex. Shown are distances (in Å) between side chain heavy atoms. (a) N…O between R15
and Asp127 (gray solid) and between R15 and Asp78 (black dotted), (b) two N…O pairs
between R8 and Asp139, (c) centroid-to-centroid between W5 and Phe130 (gray solid) and
W5 and Phe153 (black dotted), (d) O…O between S4 and Glu136 (gray solid) and N…O
between W5 and Asp139 (black dotted).
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FIGURE 3.
Binding of the LR1 ligand to the Mth ectodomain after 0 ns, 1 ns, 3 ns and 5 ns equilibration.
The receptor is colored green and the ligand magenta. Hydrogen bonds and the aromatic
interactions are specified with dotted lines and arrows, respectively.
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FIGURE 4.
Changes during the 5 ns MD simulation of key intermolecular interactions in the Mth/LR1
complex. Shown are distances (in Å) between side chain heavy atoms. (a) N…O between R15
and Asp78 (gray solid) and between R17 and Asp127 (black dotted), (b) N…O between R8
and Asp139 (gray solid) and between W5 and Asp139 (black dotted), (c) N…O between R2
and Asp154 (gray solid) and N…O between R2 and Gln138 (black dotted), (d) centroid-to-
centroid distance between F12 and Tyr131 (gray solid) and W5 and Phe130 (black dotted).
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FIGURE 5.
Calculated electron density maps (EDM). (a) The calculated EDM from the predicted Mth/
LP1 complex structure after 5 ns equilibration. The Mth ectodomain is in green, LP1 peptide
in magenta, and EDM in blue. For clarity, only the part of map covering the ligand is shown.
(b) Comparison with the experimental map (ref. 6). The Cα trace of the crystal structure is in
cyan and the experimental map in orange. The calculated maps from equilibrated structures of
1 ns, 3 ns and 5 ns are colored magenta, yellow and blue, respectively.
Heo et al. Page 16
Biochemistry. Author manuscript; available in PMC 2010 July 8.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
FIGURE 6.
Five mutant complex structures after 2 ns equilibrations in the fully solvated water box (~23000
atoms, 54×86×48 Å3).
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FIGURE 7.
The structures of WT and W5K mutant of LP1 peptide ligands after 5 ns equilibration (red) in
the fully solvated water box (4500 atoms, 36×36×44 Å3). The initial docked conformation is
colored blue.
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Table 1
Peptide ligands for the Mth ectodomain. Consensus residues from the RWR motif ([R/P]xxWxxR) are in bold
(6).
Peptidea Sequence KD(nM)b
LP1 FPSSWLQRYYLAKRR 57
LP2 MNVSWGSFPSSWLQRYYLAKRR 31
LR1 MRLVWIVRSRHFGPRLRMA 18
LR2 MAPRAVWIQRAIQAMFRLA 18
a
LP1 and LP2 correspond to a 15-mer and a 22-mer of R8-01 in ref. 6, respectively. LR1 and LR2 correspond to R8-12 and R8-14.
b
from ref. 6,
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Table 3
Comparison of experimental KD values (nM) of the LP1 peptide and mutant ligands with the energies (kcal/mol)
calculated both from the combinatorial mutation calculations and from the MD simulationsa.
KD(exp’t) ΔB.E.(calcComb)b ΔB.E.(calcMD)c ΔEint(calc)d
WT 18.5 0.00 0.00 0.00
L11Q 24.5 −5.63 −13.49 −22.66
Y9F 49.5 −0.18 −11.00 −12.88
W5F 12000 8.81 5.66 10.78
W5K No binding −4.62 6.30 8.02
R15Q 37.7 12.92 −8.63 0.91
a
Relative to WT, for the 2 ns-equilibrated complex structures after mutation
b
Calculated binding energy from combinatorial mutation calculation (from Table 2)
c
Calculated binding energy after MD; delphi solvation energy is included; B.E. (WT) = −68.25 kcal/mol
d
Intermolecular interaction energies, calculated for the residues within 5 Å of the ligand; Eint (WT) = −61.62 kcal/mol
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